Sign In
Buy TMDX
$69.69
+1.24 (+1.81%)
At Close: Jun 03, 2026
TransMedics: Extremely Undervalued And Extremely Innovative
04:54am, Wednesday, 21'st May 2025
TransMedics delivered a stellar Q1, beating revenue and EPS estimates, and raised FY25 guidance, showcasing robust growth and execution. I see significant upside from expanding organ utilization, espe
TransMedics to Present at Upcoming June Investor Conferences
04:05pm, Tuesday, 20'th May 2025
ANDOVER, Mass. , May 20, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-s
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect
10:00am, Sunday, 18'th May 2025
NEW YORK, NY / ACCESS Newswire / May 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company")
Earnings Estimates Moving Higher for TransMedics (TMDX): Time to Buy?
01:21pm, Thursday, 15'th May 2025
TransMedics (TMDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
What Makes TransMedics (TMDX) a New Buy Stock
01:05pm, Thursday, 15'th May 2025
TransMedics (TMDX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company")
2 Brilliant Stocks to Buy With $200 and Hold for 5 Years
04:51am, Wednesday, 14'th May 2025
While being an innovative company doesn't guarantee superior long-term returns, it doesn't hurt those chances either. In fact, when a corporation is making important breakthroughs and boasts significa
NEW YORK, NY / ACCESS Newswire / May 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company")
TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher?
05:18am, Tuesday, 13'th May 2025
Shares of TransMedics Group (TMDX 6.54%) recently bounded higher in response to a first-quarter earnings report that was a lot better than investors were expecting. Downward revenue guidance revisions
NEW YORK, NY / ACCESS Newswire / May 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company")
TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
01:05pm, Friday, 09'th May 2025
Increased organ utilization in liver and continued OCS adoption across both liver and heart boosted TransMedics' first-quarter 2025 performance.
Why TransMedics Stock Is Skyrocketing Today
12:42pm, Friday, 09'th May 2025
Shares of next-generation transplant technology platform TransMedics (TMDX 21.72%) were up 21% as of noon ET on Friday, according to data provided by S&P Global Market Intelligence.
TransMedics: Exceptional Q1 Undermines The Short Narrative
09:48am, Friday, 09'th May 2025
TransMedics reported extremely strong Q1 results, alleviating concerns from a weak Q3 2024 and a short attack in January. The company continues to expand its logistics capabilities and should see a bo
TransMedics Group, Inc. (TMDX) Q1 2025 Earnings Call Transcript
10:40pm, Thursday, 08'th May 2025
TransMedics Group, Inc. (NASDAQ:TMDX ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Laine Morgan - Gilmartin Group, Investor Relations Waleed Hassanein - President & Ch
Compared to Estimates, TransMedics (TMDX) Q1 Earnings: A Look at Key Metrics
08:00pm, Thursday, 08'th May 2025
The headline numbers for TransMedics (TMDX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street esti
